Open Account
Demo Account
About Us
Real-time Quotes & News
Market Analysis
Economic Calendar
Daily Market Analysis
Trading Platform
Platform Overview
How To Use
Terms
All Terms
Deposit & Withdrawal
Promotion
FAQ
Contact
繁
简
EN
User Login
Open Account
Demo Account
繁
简
EN
User Login
Open Account
Demo Account
About Us
About Aspire
Features of Aspire
Real-time Quotes & News
Real-time Quotes
Real-time News
Market Analysis
Economic Calendar
Market Analysis
Trading Platform
Meta Trader 5
Platform Features
Terms
All Terms
Deposit & Withdrawal
Promotion
FAQ
Contact
About Us
Terms
Metals Market
Trading Platform
Market Analysis
Promotion
FAQ
Contact
繁
简
EN
Hang Seng futures fell 0.37% in night trade to 25,533, trading about 120 points below the spot index.
2026-08-12
Hang Seng futures fell 0.37% in night trade to 25,533, trading about 120 points below the spot index.
Back
Other News
2026-08-12
The EIA Short-Term Energy Outlook report projects that U.S. crude oil production will increase by 350,000 barrels per day in 2027, up from the previous estimate of 250,000 barrels per day.
The EIA Short-Term Energy Outlook report projects that U.S. crude oil production will increase by 350,000 barrels per day in 2027, up from the previous estimate of 250,000 barrels per day.
2026-08-11
China NMPA, via priority review, has conditionally approved a Class 1 innovative drug, Tengogetinib tablets (brand Jientai), developed by Yaojie Ankang (Nanjing) Technology Co., Ltd. Indication: adults with advanced, metastatic or unresectable cholan
China NMPA, via priority review, has conditionally approved a Class 1 innovative drug, Tengogetinib tablets (brand Jientai), developed by Yaojie Ankang (Nanjing) Technology Co., Ltd. Indication: adults with advanced, metastatic or unresectable cholangiocarcinoma harboring FGFR2 fusions or rearrangements who have previously received systemic therapy and an FGFR inhibitor. The approval provides a new treatment option for this defined patient group.
Chat with us
, powered by
LiveChat